Login

Switch On Your HIV Smarts.

AIDS 2012 Recap: Quick HIV Treatment Research Review

AIDS 2012 Recap: Quick HIV Treatment Research Review

, by San Francisco AIDS Foundation

Ben Young, MD, of TheBodyPro.com gives a quick run-down on treatment research presented at AIDS 2012, including updates on three experimental and three approved HIV drugs. Read More

AIDS 2012: Beyond Doctors and Drugs—A Treatment as Prevention Q&A

AIDS 2012: Beyond Doctors and Drugs—A Treatment as Prevention Q&A

, by Reilly O'Neal

After leading a jam-packed workshop, STOP AIDS Project’s Jen Hecht and Justin Jones shared thoughts on what treatment as prevention means for people with HIV, and for the future. Read More

AIDS 2012: Your Day-Two Dose of Science

AIDS 2012: Your Day-Two Dose of Science

, by Reilly O'Neal

As day two of AIDS 2012 winds down, here's a quick hit of science around black gay men's health and treatment as prevention. Read More

Dolutegravir Looks Good in Another Advanced Clinical Trial

Dolutegravir Looks Good in Another Advanced Clinical Trial

, by Reilly O'Neal

Learn more about this next-generation integrase inhibitor and see how it stacks up against popular HIV drug regimen Atripla. Read More

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

, by San Francisco AIDS Foundation

New research suggests starting antiretroviral treatment reduces inflammation caused by HIV infection—but plenty of questions remain. Read More